Skip to content

A Clinical Study on the Combined Use of Neem and Haritaki in the Treatment of Eczema

Exploring samyoga (combination) of nimba (azadirachta indica linn.) with haritaki (terminalia chebula retz.) through a comparative clinical evaluation in the management of eczema - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102551
Enrollment
45
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Sponsors

Goverment Ayurveda College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient who fulfils criteria of American Academy of Dermatology

Exclusion criteria

Exclusion criteria: Patients other than inclusion criteria Known case of Diseases like D.M, Cancer, AIDS, STD, TB, Renal failure, heart disease and other disorders which can lead to fatal conditions and Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To evaluate ideology of Samyoga (combination) through clinical application when Nimba (Azadirachta indica Linn.) and Haritaki (Terminalia chebula Retz.) are given in the management of eczema.Timepoint: 30 Days

Secondary

MeasureTime frame
1.To conduct a literature review on ideology of Samyoga (combination) through clinical application. 2.To conduct literary review on the Nimba (Azadirachta indica Linn.), Haritaki (Terminalia chebula Retz.), and eczema. 3.To conduct Pharmacognostical and analytical study of Nimba (Azadirachta indica Linn.) and Haritaki (Terminalia chebula Retz.). Timepoint: 30 Days

Countries

India

Contacts

Public ContactDr Dilip Jani

Goverment Ayurveda College Vadodara

drdilipjn@gmail.com9925941861

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026